Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology

Sponsor
Neolys
Study ID
NCT06033183
Status
Recruiting
Apply to this trial

Conditions

  • Pediatric Cancer
  • Radiation Toxicity
  • Radiosensitivity

Eligibility Criteria

Sex
ALL
Age
3 Years - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • Blood sample — BIOLOGICAL
    Blood sample collection : 2 X 5 ml

Study Details

Analysis of the individual radiosensitivity in pediatric oncology

Key Dates

First listed
Sep 13, 2023
Start date
Dec 2, 2023
Status verified
Nov 2024
Primary completion
Aug 30, 2027
Completion
Oct 30, 2027

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING

Arms

  • Experimental: Radiosensitivity
    Patients who agree to participate in this research study will have blood sample collected to perform the RadioDtect test

Primary Outcome Measure

Prospectively validate the discriminating capacities of the RadioDtect© individual radiosensitivity blood test on the occurrence of early radio-induced toxicities. [ Time Frame: 24 months ]

Central Contacts

Related Studies